Induction of chemokine expression by adiponectin in vitro is isoform dependent

Translational Research

Volumn 154, Issue 1, 2009, Pages 18-26

  Song, Huijuan ^a   Chan, James ^a   Rovin, Brad H ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; EDETIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; ISOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENSITY GRADIENT CENTRIFUGATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MESANGIUM CELL; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

EID: 66649119136     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2009.04.003     Document Type: Article

References (46)

1. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., and Matsubara K. cDNA cloning and expression of a novel adipose specifice collagen-like factor, apM1. Biochem Biophys Res Comm 221 (1996) 286-289
2. Diez J.J., and Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endo 148 (2003) 293-300
3. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 (2001) 941-946
4. Berg A.H., Combs T.P., Du X., Brownlee M., and Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7 (2001) 947-953
5. Fruebis J., Tsao T.-S., Javorschi S., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98 (2001) 2005-2010
6. Schalkwijk C.G., Chaturvedi N., Schram M.T., Fuller J.H., and Stehouwer C.D.A. Adiponectin is inversely associated with renal function in type 1 diabetic patients. J Clin Endo Metab 91 (2006) 129-135
7. Gueere-Millo M. Adiponectin: an update. Diabetes Metab 34 (2008) 12-18
8. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Comm 257 (1999) 79-83
9. Tsao T.-S., Murrey H.E., Hug C., Lee D.H., and Lodish H.F. Oligomerization state-dependent activation of NF-kB signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem 277 (2002) 29359-29362
10. Peake P.W., Kriketos A.D., Campbell L.V., Shen Y., and Charlesworth J.A. The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. Eur J Endo 153 (2005) 409-417
11. Yamauchi T., Kamon J., Ito Y., et al. Cloning of adiponectin receptors that mediate anitdiabetic metabolic effects. Nature 423 (2003) 762-769
12. Wang H., Zhang H., Jia Y., et al. Adiponectin receptor 1 gene as a candidate for type 2 diabetes and insulin resistance. Diabetes 53 (2004) 2132-2136
13. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endo Rev 26 (2005) 439-451
14. Kadowaki T., Yamauchi T., and Kubota N. The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett 582 (2008) 74-80
15. Viollet B., Mounier R., Leclerc J., Yazigi A., Foretz M., and Andreelii F. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes Metab 33 (2007) 395-402
16. Tsao T.-S., Tomas E., Murrey H.E., et al. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. J Biol Chem 278 (2003) 50810-50817
17. Rovin B.H., Song H., Hebert L.A., et al. Plasma, urine, and renal expresssion of adiponectin in human systemic lupus erythematosus. Kidney Int 68 (2005) 1825-1833
18. Wulster-Radcliffe M.C., Ajuwon K.M., Wang J., Christian J.A., and Spurlock M.E. Adiponectin differentially regulates cytokines in procine macrophages. Biochem Biophys Res Comm 316 (2004) 924-929
19. Ouchi N., Kihara S., Arita Y., et al. Novel modulator for endothelial adhesion molecules. Circulation 100 (1999) 2473-2476
20. Kawanami D., Maemura K., Takeda N., et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Comm 314 (2004) 415-419
21. Kumada M., Kihara S., Noriyuki O., et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 109 (2004) 2046-2049
22. Berg A.H., and Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96 (2005) 939-949
23. Rovin B.H., and Song H. Chemokine induction by the adipocyte-derived cytokine adiponectin. Clin Immunol 120 (2006) 99-105
24. Saijo S., Nagata K., Nakano Y., Tobe T., and Kobayashi Y. Inhibition by adiponectin of IL-8 production by human macrophages upon coculturing with late apoptotic cells. Biochem Biophys Res Comm 334 (2005) 1180-1183
25. Lappas M., Permezel M., and Rice G.E. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kB, peroxisomal proliferator-activated receptor-gamma, and extracellularly regulated kinase 1/2. Endocrinology 146 (2005) 3334-3343
26. Chen T.-H., Chen L., Hsieh M.-S., Chang C.-P., Chou D.-T., and Tsai S.-H. Evidence for a protective role for adiponectin in osteoarthritis. Biochim Biophys Acta 1762 (2006) 711-718
27. Ehling A., Schaffler A., Herfarth H., et al. The potential of adiponectin in driving arthritis. J Immunol 176 (2006) 4468-4478
28. Neumeier M., Weigert J., Schaffler A., et al. Different effects of adiponectin isoforms in human moncytic cells. J Leuk Biol 79 (2006) 803-808
29. Delaigle A.M., Jonas J.-C., Bauche I.B., Cornu O., and Brichard S.M. Induction of adipokines in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 145 (2004) 5589-5597
30. Katsiougiannis S., Kapsogeorgou E.K., Manoussakis M.N., and Skopouli F.N. Salivary gland epithelial cells: a new source of the immunoregulatory hormone adiponectin. Arthritis Rheum 54 (2006) 2295-2299
31. Takemura Y., Osuga Y., Yamauchi T., et al. Expression of adiponectin receptors and its possible implication in the human endometrium. Endocrinology 147 (2006) 3203-3210
32. Takahashi T., Yu F., Saegusa S., et al. Impaired expression of cardiac adiponectin in leptin-deficient mice with viral myocarditis. Int Heart J 47 (2006) 107-123
33. Pajvani U.B., Du X., Combs T.P., et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/Adiponectin. J Biol Chem 278 (2003) 9073-9085
34. Haugen F., and Drevon C.A. Activation of nuclear factor-kB by high molecular weight and globular adiponectin. Endocrinology 148 (2007) 5478-5486
35. Rovin B.H. Chemokines as therapeutic targets in renal inflammation. Am J Kid Dis 34 (1999) 761-764
36. Rovin B.H. The chemokine network in systemic lupus erythematosis nephritis. Frontiers in Bioscience 13 (2007) 904-922
37. Marsh C.B., Wewers M.D., Tan L.C., and Rovin B.H. FcgammaR cross-linking induces peripheral blood mononuclear cell MCP-1 expression: role of lymphocyte FcgammaR III. J Immunol 158 (1997) 1078-1084
38. Xu Y., Swerlick R.A., Sepp N., Boss D., Ades E.W., and Lawley T.J. Characterization of expression and modulation of cell adhesion molecules on an immortalized human dermal microvascular endothelial cell line (HMEC-1). J Invest Dermatol 102 (1994) 833-837
39. Rovin B.H., Yoshiumura T., and Tan L. Cytokine induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 148 (1992) 2148-2153
40. Wang Y., Lam K.S.L., Xu J.Y., et al. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 280 (2005) 18341-18347
41. Yamauchi T., Nio Y., Maki T., et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13 (2007) 332-339
42. Hug C., Wang J., Ahmad N.S., Bogan J.S., Tsao T.-S., and Lodish H.F. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci USA 101 (2004) 10308-10313
43. Schober F., Neumeier M., Weigert J., et al. Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release. Biochem Biophys Res Comm 361 (2007) 968-973
44. Koshimura J., Fujita H., Narita T., et al. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Comm 316 (2004) 165-169
45. Ruster C., and Wolf G. The role of chemokines and chemokine receptors in diabetic nephropathy. Frontiers in Bioscience 13 (2008) 944-955
46. Tesch G.H. MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol 294 (2008) F697-F701